找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Clinical Applications of SPECT-CT; Hojjat Ahmadzadehfar,Hans-Jürgen Biersack Book 20141st edition Springer-Verlag Berlin Heidelberg 2014 B

[復(fù)制鏈接]
樓主: 浮華
41#
發(fā)表于 2025-3-28 16:50:41 | 只看該作者
42#
發(fā)表于 2025-3-28 19:58:28 | 只看該作者
43#
發(fā)表于 2025-3-29 02:59:22 | 只看該作者
Vorgehensweise: Methodologie und Methode, from malignant conditions to trauma, infection, and benign conditions. Despite recent advances in anatomical imaging such as magnetic resonance imaging (MRI) and computed tomography (CT), bone scintigraphy continues to play a major role in the diagnosis of bone pathology. The key advantages of bone
44#
發(fā)表于 2025-3-29 05:47:42 | 只看該作者
45#
發(fā)表于 2025-3-29 09:02:42 | 只看該作者
46#
發(fā)表于 2025-3-29 12:20:34 | 只看該作者
Rituals and Student Identity in Educationnatomic information and functional data and leads to a better localization and definition of scintigraphic findings. Besides anatomic referencing, the other advantage of CT co-registration is the attenuation correction capabilities of CT. These advantages together result in a higher specificity of i
47#
發(fā)表于 2025-3-29 17:18:53 | 只看該作者
?... Wessen Welt ist die Welt?“Likely, most nuclear clinicians will naturally acknowledge that SPECT/CT is the best tool beside PET/CT to get an accurate individual dosimetry in internal radiotherapy. But is it really needed? Often, internal radiotherapies are performed without any real individual dosimetry assessment. So why should we use the state-of-the-art SPECT/CT system?
48#
發(fā)表于 2025-3-29 21:49:12 | 只看該作者
49#
發(fā)表于 2025-3-30 00:43:16 | 只看該作者
50#
發(fā)表于 2025-3-30 04:43:58 | 只看該作者
https://doi.org/10.1007/978-3-031-54431-6The accurate diagnosis of pulmonary embolism (PE) is challenging for both clinicians and imaging specialists. Misdiagnosis must be avoided because untreated PE has a mortality rate reported to be up to 30 %, and unnecessary treatment with anticoagulation places patients at risk of bleeding [1–3].
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-9 23:43
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
讷河市| 宁强县| 讷河市| 云和县| 石阡县| 嘉禾县| 微山县| 南开区| 德格县| 许昌县| 景德镇市| 壤塘县| 罗山县| 青冈县| 武鸣县| 绵阳市| 梁山县| 泽库县| 武山县| 拉萨市| 北海市| 克东县| 敦煌市| 兴义市| 平泉县| 永年县| 舒城县| 平南县| 泗水县| 高密市| 上思县| 浑源县| 西盟| 泰来县| 潼南县| 鞍山市| 依兰县| 分宜县| 克什克腾旗| 皋兰县| 突泉县|